Fore Biotherapeutics
Philadelphia
About Fore Biotherapeutics
Fore Biotherapeutics is a precision oncology company specializing in cancer therapies guided by functional genomics. The company is creating a pipeline of precision oncology treatments aimed at patients with unaddressed mutations across well-established oncology targets.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $206.7M
- Funding stage: Late Stage Venture
- Last round: Series D (May 2025)
- Website: fore.bio
- Phone: 267-641-7575
Industries & Categories
Biotechnology, Health Care, Health Diagnostics, Medical, Oncology
Social Profiles
Canonical: https://fsome.com/organization/fore-biotherapeutics-49870 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.